Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01135875 · ClinicalTrials.gov registry record
Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 130
- Enrollment target
NCT01135875: Completed study, sponsored by University of Florida.
NCT01135875 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 130 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01135875 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 130 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if tumor cells can be detected in the blood of patients diagnosed with a brain tumor.
Primary Outcome
Already established and stored GBM cell lines will be screened for CD antigens to confirm that a selective cell surface antigen can be identified.
Interventions
- OTHER GBM Patients
- OTHER Normal Controls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2009-10 |
| Est. Completion | 2013-04 |
What the finished NCT01135875 record still lists
NCT01135875 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which GBM Patients is the first listed.
NCT01135875 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01135875 about?
NCT01135875 is a clinical study titled "Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients". The purpose of this study is to determine if tumor cells can be detected in the blood of patients diagnosed with a brain tumor.
What is the current status of trial NCT01135875?
This trial is currently completed. The enrollment target is 130 participants. The study started on 2009-10. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01135875?
The interventions under investigation include: GBM Patients (OTHER), Normal Controls (OTHER).
Who is sponsoring clinical trial NCT01135875?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia